Why are clinicians not embracing the results from pivotal clinical trials in severe sepsis? A bayesian analysis.
<h4>Background</h4>Five pivotal clinical trials (Intensive Insulin Therapy; Recombinant Human Activated Protein C [rhAPC]; Low-Tidal Volume; Low-Dose Steroid; Early Goal-Directed Therapy [EGDT]) demonstrated mortality reduction in patients with severe sepsis and expert guidelines have re...
Saved in:
Main Authors: | Andre C Kalil, Junfeng Sun |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2008
|
Subjects: | |
Online Access: | https://doaj.org/article/b2d19aafa17f44e1a4056f95494bca50 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinician Delivery of Virtual Pivotal Response Treatment with Children with Autism during the COVID-19 Pandemic
by: Devon M. White, et al.
Published: (2021) -
The design of a Bayesian adaptive clinical trial of tranexamic acid in severely injured children
by: John M. VanBuren, et al.
Published: (2021) -
Dignity of Older Persons With Mental Health Conditions: Why Should Clinicians Care?
by: Debanjan Banerjee, et al.
Published: (2021) -
How to read a published clinical trial: a practical guide for clinicians
by: Mohamad B Sonbol, et al.
Published: (2020) -
Embracing the Complexity of Neurodevelopmental Disorders
by: Michele Roccella, et al.
Published: (2021)